Design, validation and implementation of an automated e-alert for acute kidney injury: 6-month pilot study shows increased awareness.
AKI
Before-after study
Data science
E-alert
Electronic health records
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
27 07 2023
27 07 2023
Historique:
received:
03
04
2023
accepted:
07
07
2023
medline:
31
7
2023
pubmed:
28
7
2023
entrez:
27
7
2023
Statut:
epublish
Résumé
Acute kidney injury (AKI) is defined as a sudden episode of kidney failure but is known to be under-recognized by healthcare professionals. The Kidney Disease Improving Global Outcome (KDIGO) guidelines have formulated criteria to facilitate AKI diagnosis by comparing changes in plasma creatinine measurements (PCr). To improve AKI awareness, we implemented these criteria as an electronic alert (e-alert), in our electronic health record (EHR) system. For every new PCr measurement measured in the University Medical Center Utrecht that triggered the e-alert, we provided the physician with actionable insights in the form of a memo, to improve or stabilize kidney function. Since e-alerts qualify for software as a medical device (SaMD), we designed, implemented and validated the e-alert according to the European Union In Vitro Diagnostic Regulation (IVDR). We evaluated the impact of the e-alert using pilot data six months before and after implementation. 2,053 e-alerts of 866 patients were triggered in the before implementation, and 1,970 e-alerts of 853 patients were triggered after implementation. We found improvements in AKI awareness as measured by (1) 2 days PCr follow up (56.6-65.8%, p-value: 0.003), and (2) stop of nephrotoxic medication within 7 days of the e-alert (59.2-63.2%, p-value: 0.002). Here, we describe the design and implementation of the e-alert in line with the IVDR, leveraging a multi-disciplinary team consisting of physicians, clinical chemists, data managers and data scientists, and share our firsts results that indicate an improved awareness among treating physicians.
Sections du résumé
BACKGROUND
Acute kidney injury (AKI) is defined as a sudden episode of kidney failure but is known to be under-recognized by healthcare professionals. The Kidney Disease Improving Global Outcome (KDIGO) guidelines have formulated criteria to facilitate AKI diagnosis by comparing changes in plasma creatinine measurements (PCr). To improve AKI awareness, we implemented these criteria as an electronic alert (e-alert), in our electronic health record (EHR) system.
METHODS
For every new PCr measurement measured in the University Medical Center Utrecht that triggered the e-alert, we provided the physician with actionable insights in the form of a memo, to improve or stabilize kidney function. Since e-alerts qualify for software as a medical device (SaMD), we designed, implemented and validated the e-alert according to the European Union In Vitro Diagnostic Regulation (IVDR).
RESULTS
We evaluated the impact of the e-alert using pilot data six months before and after implementation. 2,053 e-alerts of 866 patients were triggered in the before implementation, and 1,970 e-alerts of 853 patients were triggered after implementation. We found improvements in AKI awareness as measured by (1) 2 days PCr follow up (56.6-65.8%, p-value: 0.003), and (2) stop of nephrotoxic medication within 7 days of the e-alert (59.2-63.2%, p-value: 0.002).
CONCLUSION
Here, we describe the design and implementation of the e-alert in line with the IVDR, leveraging a multi-disciplinary team consisting of physicians, clinical chemists, data managers and data scientists, and share our firsts results that indicate an improved awareness among treating physicians.
Identifiants
pubmed: 37501175
doi: 10.1186/s12882-023-03265-4
pii: 10.1186/s12882-023-03265-4
pmc: PMC10375640
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
222Informations de copyright
© 2023. The Author(s).
Références
Clin Chem Lab Med. 2007;45(1):13-9
pubmed: 17243908
Nat Rev Nephrol. 2021 Jul;17(7):493-502
pubmed: 33712812
J Med Internet Res. 2022 Nov 18;24(11):e40516
pubmed: 36399373
Am J Nephrol. 2012;35(4):349-55
pubmed: 22473149
J Am Soc Nephrol. 2018 Feb;29(2):654-660
pubmed: 29097621
Nephron. 2015;131(2):113-7
pubmed: 26351847
Nephrol Dial Transplant. 2017 Feb 1;32(2):265-272
pubmed: 28088774
BMC Nephrol. 2021 Nov 8;22(1):371
pubmed: 34749693
Clin Chem Lab Med. 2022 May 11;60(7):982-988
pubmed: 35538674
NPJ Digit Med. 2019 Jul 31;2:67
pubmed: 31396561
Dtsch Arztebl Int. 2017 Jan 9;114(1-02):1-8
pubmed: 28143633
Can J Kidney Health Dis. 2016 Feb 26;3:10
pubmed: 26925246
Crit Care Clin. 2020 Jan;36(1):125-140
pubmed: 31733675
Curr Opin Nephrol Hypertens. 2013 Nov;22(6):637-42
pubmed: 24100217
Crit Care Clin. 2021 Apr;37(2):251-266
pubmed: 33752854
Lancet. 2019 Nov 23;394(10212):1949-1964
pubmed: 31777389
Kidney Int. 2020 Aug;98(2):294-309
pubmed: 32709292